0001127602-22-020417.txt : 20220803
0001127602-22-020417.hdr.sgml : 20220803
20220803174153
ACCESSION NUMBER: 0001127602-22-020417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220803
DATE AS OF CHANGE: 20220803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Salmon Sean
CENTRAL INDEX KEY: 0001792380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 221133869
MAIL ADDRESS:
STREET 1: MEDTRONIC PLC, 710 MEDTRONIC PARKWAY
STREET 2: LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0428
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-08-01
0001613103
Medtronic plc
MDT
0001792380
Salmon Sean
710 MEDTRONIC PARKWAY
MINNEAPOLIS
MN
55432
1
EVP & President Cardiovascular
Ordinary Shares
2022-08-01
4
A
0
8595
0
A
36214
D
Performance Share Units
2022-08-01
4
A
0
21487
0
A
Performance Share Units
21487
21487
D
Stock Option (Right to Buy)
93.08
2022-08-01
4
A
0
67924
0
A
2032-08-01
Ordinary Shares
67924
67924
D
The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,487 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Vests on August 1, 2025.
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
/s/ Thomas L. Osteraas, attorney-in-fact
2022-08-03